Clinical Trial Update: Effect of Arotinolol Hydrochloride on Cardiovascular Events in Hypertensive Haemodialysis Patients [Phase 4]

View source ↗

Summary

Phase 4 trial assessing the effect of arotinolol hydrochloride on cardiovascular events in hypertensive patients undergoing haemodialysis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Disease
• Chronic Kidney Disease
• Hypertension

Drugs mentioned

• Arotinolol hydrochloride (arotinolol hydrochloride)

Snippet

Sponsor: Sumitomo Pharma (Suzhou) Co., Ltd. | Conditions: Chronic Kidney Disease | Phase 4 | Status: COMPLETED